News

The research is focused on identifying biomarkers, non-ambulatory endpoints in duchenne muscular dystrophy. Funds will allow recruitment of 100 additional subjects and expand the study through the 20

Treatment methods with IL-17E include single and combination therapy along with anticancer drugs such as gemcitabine, paclitaxel, docetaxel, erlotinib, cisplatin and bevacizumab. Patent also protects the treatment of

Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent to Watson Laboratories’ Lutera 28 tablets indicated to prevent pregnancy in women. Lupin is expected to begin the product

The 13C- and 15N-labeled phytochemicals and plant products can be used in food & beverage, nutraceutical, pharmaceutical, cosmeceutical and environmental sciences research as tracers and internal standards. ChromaDex

Adaptimmune will make use of PCT services in the development of its NYESO-1c259-T cell therapy targeting various oncology indications. Adaptimmune chief executive officer James Noble said, "With our

US patent protects various aspects of the cell-based product including rhodamine derivative’s composition of matter, vital steps involved in ATIR manufacturing process and therapeutic use of ATIR in

The collaboration aims at leveraging Amunix’s XTEN half-life extension technology in Janssen’s protein and/or peptide therapeutics. Amunix president Volker Schellenberger said XTEN polymer can be integrated with a

The alliance will also focus on commercializing network, thereby enhancing the rate of translating academic research into new medicines. Founding organizations include The Centre for Drug Research and

The study is designed to assess rIX-FP’s safety, efficacy and pharmacokinetic profile in children who previously received treatment. CSL Behring along with its parent company, CSL Limited, is